Current Ratio in % of Inmune Bio, Inc. from Q1 2020 to Q3 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Inmune Bio, Inc. quarterly Current Ratio history and change rate from Q1 2020 to Q3 2025.
  • Inmune Bio, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 355 %, a 62.9% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Inmune Bio, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 355 +137 +62.9% 30 Sep 2025
Q2 2025 308 +76.6 +33.2% 30 Jun 2025
Q1 2025 261 -4.11 -1.55% 31 Mar 2025
Q4 2024 231 -116 -33.4% 31 Dec 2024
Q3 2024 218 -234 -51.8% 30 Sep 2024
Q2 2024 231 -354 -60.5% 30 Jun 2024
Q1 2024 265 -586 -68.9% 31 Mar 2024
Q4 2023 347 -849 -71% 31 Dec 2023
Q3 2023 452 -1.32K -74.5% 30 Sep 2023
Q2 2023 585 -1.6K -73.2% 30 Jun 2023
Q1 2023 852 -1.06K -55.5% 31 Mar 2023
Q4 2022 1.2K -663 -35.7% 31 Dec 2022
Q3 2022 1.77K +2.19 +0.12% 30 Sep 2022
Q2 2022 2.19K +488 +28.7% 30 Jun 2022
Q1 2022 1.92K +329 +20.7% 31 Mar 2022
Q4 2021 1.86K +722 +63.6% 31 Dec 2021
Q3 2021 1.77K +721 +68.8% 30 Sep 2021
Q2 2021 1.7K +861 +103% 30 Jun 2021
Q1 2021 1.59K +384 +32% 31 Mar 2021
Q4 2020 1.14K 31 Dec 2020
Q3 2020 1.05K 30 Sep 2020
Q2 2020 839 30 Jun 2020
Q1 2020 1.2K 31 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.